Can-Fite BioPharma Ltd. (CANF)
3.35
+0.02
(+0.60%)
USD |
NYAM |
Aug 24, 16:00
3.47
+0.12
(+3.58%)
After-Hours: 07:44
Can-Fite BioPharma Max Drawdown (5Y) : 99.43% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.43% |
| June 30, 2026 | 99.43% |
| May 31, 2026 | 99.41% |
| April 30, 2026 | 99.41% |
| March 31, 2026 | 99.41% |
| February 28, 2026 | 99.41% |
| January 31, 2026 | 99.41% |
| December 31, 2025 | 99.41% |
| November 30, 2025 | 99.32% |
| October 31, 2025 | 99.32% |
| September 30, 2025 | 99.32% |
| August 31, 2025 | 99.32% |
| July 31, 2025 | 99.32% |
| June 30, 2025 | 99.32% |
| May 31, 2025 | 99.32% |
| April 30, 2025 | 99.32% |
| March 31, 2025 | 99.32% |
| February 28, 2025 | 99.32% |
| January 31, 2025 | 99.32% |
| December 31, 2024 | 99.32% |
| November 30, 2024 | 99.32% |
| October 31, 2024 | 99.32% |
| September 30, 2024 | 99.32% |
| August 31, 2024 | 99.32% |
| July 31, 2024 | 99.32% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.32% |
| May 31, 2024 | 99.32% |
| April 30, 2024 | 99.32% |
| March 31, 2024 | 99.32% |
| February 29, 2024 | 99.32% |
| January 31, 2024 | 99.32% |
| December 31, 2023 | 99.32% |
| November 30, 2023 | 99.32% |
| October 31, 2023 | 99.32% |
| September 30, 2023 | 99.32% |
| August 31, 2023 | 99.32% |
| July 31, 2023 | 99.32% |
| June 30, 2023 | 99.32% |
| May 31, 2023 | 99.32% |
| April 30, 2023 | 99.32% |
| March 31, 2023 | 99.11% |
| February 28, 2023 | 99.11% |
| January 31, 2023 | 98.96% |
| December 31, 2022 | 98.64% |
| November 30, 2022 | 98.64% |
| October 31, 2022 | 98.64% |
| September 30, 2022 | 98.64% |
| August 31, 2022 | 98.64% |
| July 31, 2022 | 98.64% |
| June 30, 2022 | 98.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BioLineRx Ltd. | 98.88% |
| XTL Biopharmaceuticals Ltd. | 90.10% |
| Kamada Ltd. | 67.69% |
| Galmed Pharmaceuticals Ltd. | 99.94% |
| Revium Recovery, Inc. | 98.64% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -75.89 |
| Beta (5Y) | 1.107 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.36% |
| Historical Sharpe Ratio (5Y) | -1.054 |
| Historical Sortino (5Y) | -1.727 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.87% |